Welte, Thomas

Mutual regulation of tumour vessel normalization and immunostimulatory reprogramming

Tian, L., Goldstein, A., Wang, H., Ching Lo, H., Sun Kim, I., Welte, T., Sheng, K., Dobrolecki, L. E., Zhang, X., Putluri, N., et al. (2017) · Nature

Angiogenesis and VEGF in CancerCancer Immunotherapy and Biomarkers

Cited by 841

STAT3 deletion during hematopoiesis causes Crohn’s disease-like pathogenesis and lethality: a critical role of STAT3 in innate immunity

Welte, T., Zhang, S. S. M., Wang, T., Zhang, Z., Hesslein, D. G. T., Yin, Z., Kano, A., Iwamoto, Y., Li, E., Craft, J. E., et al. (2003) · Proceedings of the National Academy of Sciences

Cytokine Signaling Pathways and InteractionsInflammatory Bowel Disease

Cited by 381

STAT3 is required for Flt3L-dependent dendritic cell differentiation

Laouar, Y., Welte, T., Fu, X.-Y., & Flavell, R. A. (2003) · Immunity

Cytokine Signaling Pathways and InteractionsImmunotherapy and Immune Responses

Cited by 334

Nanoplatforms for mRNA Therapeutics

Meng, C., Chen, Z., Li, G., Welte, T., & Shen, H. (2021) · Advanced Therapeutics

RNA Interference and Gene DeliveryNanoparticle-Based Drug Delivery

Cited by 130